OAM
Ostrum Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.82M | Sell |
14,525
-183
| -1% | -$23K | 0.09% | 207 |
|
2025
Q1 | $2.01M | Sell |
14,708
-173
| -1% | -$23.7K | 0.11% | 189 |
|
2024
Q4 | $2.28M | Sell |
14,881
-7,023
| -32% | -$1.07M | 0.2% | 166 |
|
2024
Q3 | $4.25M | Buy |
21,904
+167
| +0.8% | +$32.4K | 0.35% | 59 |
|
2024
Q2 | $5.04M | Sell |
21,737
-1,056
| -5% | -$245K | 0.44% | 43 |
|
2024
Q1 | $4.91M | Buy |
22,793
+2,483
| +12% | +$535K | 0.39% | 55 |
|
2023
Q4 | $5.26M | Buy |
20,310
+9,112
| +81% | +$2.36M | 0.46% | 43 |
|
2023
Q3 | $2.88M | Buy |
11,198
+56
| +0.5% | +$14.4K | 0.27% | 107 |
|
2023
Q2 | $3.17M | Buy |
11,142
+720
| +7% | +$205K | 0.27% | 117 |
|
2023
Q1 | $2.9M | Buy |
+10,422
| New | +$2.9M | 0.25% | 130 |
|
2019
Q1 | – | Sell |
-2,163
| Closed | -$651K | – | 146 |
|
2018
Q4 | $651K | Buy |
+2,163
| New | +$651K | 0.26% | 113 |
|